HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.

Abstract
We investigated whether [(123)I]-beta-CIT and single-photon emission computed tomography (SPECT) imaging distinguishes patients with clinically suspected vascular parkinsonism (VP) from patients with idiopathic Parkinson's disease (PD). [(123)I]beta-CIT SPECT is a sensitive marker of dopaminergic degeneration, and the degree of striatal binding reduction in PD correlates with disease severity. Thirteen patients who fulfilled rigid clinical criteria for VP (mean +/- S.D.: age, 76.5 +/- 5.3 years; disease duration, 3.6 +/- 2.8 years), 20 PD patients (age, 66.2 +/- 9.5 years; disease duration, 4.3 +/- 2.7 years), and 30 healthy persons (age, 44.6 +/- 19.2 years) underwent [(123)I]beta-CIT SPECT imaging. Age-corrected striatal beta-CIT binding was reduced on average by 40.8% in PD but was near normal in the VP group (mean reduction, 1.2%). This difference was statistically significant (Z = 4.68; P < 0.001). The left-right asymmetry of striatal beta-CIT binding was significantly increased in the PD group compared with normal controls and the VP group (F(2) = 17.4, P <0.001). Moreover, putamen-caudate nucleus ratios were significantly reduced in PD compared with both VP patients and healthy controls (F(2) = 65.5, P < 0.001). Whole striatal beta-CIT binding was more than one standard deviation above the mean PD values in all but one of the individual VP patients. Our findings suggest that the presynaptic dopaminergic deficits seen in PD are absent in most patients with VP. [(123)I]beta-CIT SPECT imaging may be useful to help distinguish between PD and VP patients during life.
AuthorsWillibald Gerschlager, Gerhard Bencsits, Walter Pirker, Bastiaan R Bloem, Susanne Asenbaum, Daniella Prayer, Jan C M Zijlmans, Martha Hoffmann, Thomas Brücke
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 17 Issue 3 Pg. 518-23 (May 2002) ISSN: 0885-3185 [Print] United States
PMID12112200 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright 2002 Movement Disorder Society
Chemical References
  • Radiopharmaceuticals
  • 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane
  • Cocaine
  • Dopamine
Topics
  • Aged
  • Aged, 80 and over
  • Cocaine (analogs & derivatives)
  • Corpus Striatum (diagnostic imaging, metabolism)
  • Diagnosis, Differential
  • Dopamine (metabolism)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nerve Degeneration (diagnostic imaging, metabolism)
  • Parkinson Disease (diagnostic imaging, metabolism)
  • Parkinson Disease, Secondary (diagnostic imaging, metabolism)
  • Radiopharmaceuticals
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: